Loading…
McKesson Corporation is projected to rise to $858.65 by 2027, a +14% move from its current price of $756.47. MCK is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $746.90 | $756.62 | $766.48 | +0.02% |
| May 30 | $743.05 | $756.78 | $770.76 | +0.04% |
| May 31 | $740.16 | $756.93 | $774.09 | +0.06% |
| Jun 1 | $737.74 | $757.09 | $776.94 | +0.08% |
| Jun 2 | $735.64 | $757.24 | $779.47 | +0.10% |
| Jun 3 | $733.76 | $757.40 | $781.79 | +0.12% |
| Jun 4 | $732.05 | $757.55 | $783.94 | +0.14% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $732.05 | $757.55 | $783.94 | +0.14% |
| Week 2 | $722.77 | $758.63 | $796.27 | +0.29% |
| Week 3 | $715.97 | $759.71 | $806.13 | +0.43% |
| Week 4 | $710.45 | $760.80 | $814.72 | +0.57% |
| Week 5 | $705.73 | $761.88 | $822.50 | +0.72% |
| Week 6 | $701.59 | $762.97 | $829.72 | +0.86% |
| Week 7 | $697.89 | $764.06 | $836.51 | +1.00% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
McKesson Corporation, symbol MCK, is a healthcare company that provides services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions.
The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions; it also provides logistics and distribution services for manufacturers. It also provides consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies; gene therapy with InspiroGene, practice consulting, and vaccine distribution services; and technology solutions, as well as research, insights, technologies, and services to improve cancer and specialty care. In addition, it helps in solving medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies.
McKesson was founded in 1833 and is headquartered in Irving, Texas.
McKesson Corporation is a large healthcare services provider ranked 170 with a market cap of $92.09B. The stock is currently priced at $766.08 per share. These rankings reflect its position in the market and the size of its enterprise.
The forecast suggests a substantial upside path over time, with the average price rising from $766.08 in 2026 to $1,133.96 by 2030, then to $2,599.81 by 2040 and $4,584.79 by 2050, with a maximum projected price reaching $7,502.56 by 2050. This implies meaningful potential upside from the current level across the multi-year horizon.
By year, the forecast shows a continued bullish trajectory after 2029, supporting a longer-term case for appreciation, albeit with inherent uncertainty and not a guarantee of future results.
A major floor 15.3% below — a decisive break under it would weaken the trend.
The nearest floor, 4.1% below — buyers have tended to step in here.
The nearest ceiling, 14.7% above — a clean break opens room to run.
A major ceiling 31.6% above — clearing it would confirm fresh momentum.
Key MCK support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of MCK market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $759.63 | Sell | $758.72 | Sell |
| MA 10 | $758.10 | Sell | $760.46 | Sell |
| MA 20 | $766.80 | Sell | $773.55 | Sell |
| MA 50 | $826.68 | Sell | $813.29 | Sell |
| MA 100 | $860.42 | Sell | $831.26 | Sell |
| MA 200 | $817.39 | Sell | $810.10 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 38.94 | Neutral |
| Stoch RSI (14) | 86.60 | Sell |
| CCI (20) | -29.21 | Neutral |
| Williams %R (14) | -38.39 | Info |
| MACD (12,26,9) | 4.39 | Buy |
| ROC (12) | 2.77 | Buy |
| Bollinger %B (20,2) | 0.41 | Neutral |
| Stochastic %K (14) | 61.61 | Neutral |
| TRIX (15) | -0.47 | Sell |
| Awesome (5,34) | -42.07 | Sell |
| Ultimate (7,14,28) | 46.72 | Neutral |
| Momentum (10) | 21.78 | Buy |
| Aroon Osc (25) | -56.00 | Sell |
| Hull MA (9) | 759.45 | Sell |
| ADX (14) | 32.08 | Sell |
| ATR (14) | 9.85 | Info |
Near-term technicals show a neutral setup. The RSI(14) is 40, which sits in the lower half of typical ranges. The market trades with a neutral tilt rather than a clearly bullish or bearish bias.
Moving averages place the price around the mid-to-upper area of the recent history, with the SMA50 at $834.14 and the SMA200 at $816.49. This alignment suggests price action is hovering near the convergence area of short- and longer-term averages.
In the 30-day window, the stock has a range from $701.55 to $836.54, with a support level at $725.17 and a resistance level at $867.34. These levels provide near-term reference points for potential pullbacks or rallies.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $725.17 | $756.47 | $983.11 | 0% | Neutral | |
| $701.46 | $858.65 | $1,100.19 | +14% | Neutral | |
| $699.76 | $872.21 | $1,146.76 | +15% | Neutral | |
| $784.22 | $992.28 | $1,331.77 | +31% | Bullish | |
| $855.25 | $1,096.58 | $1,497.80 | +45% | Bullish | |
| $944.85 | $1,226.10 | $1,700.80 | +62% | Bullish | |
| $1,091.58 | $1,432.36 | $2,014.85 | +89% | Bullish | |
| $1,133.63 | $1,503.09 | $2,141.43 | +99% | Bullish | |
| $1,149.36 | $1,539.01 | $2,218.58 | +103% | Bullish | |
| $1,198.40 | $1,619.78 | $2,360.79 | +114% | Bullish | |
| $1,749.00 | $2,465.20 | $3,764.14 | +226% | Bullish | |
| $2,847.67 | $4,304.01 | $7,042.53 | +469% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $725.17 | $756.47 | $888.29 | +0.00% |
| June 2026 | $663.37 | $773.86 | $920.26 | +2.30% |
| July 2026 | $656.84 | $770.66 | $925.13 | -0.41% |
| August 2026 | $663.39 | $781.85 | $945.39 | +1.45% |
| September 2026 | $680.27 | $804.72 | $978.82 | +2.92% |
| October 2026 | $677.20 | $803.82 | $983.00 | -0.11% |
| November 2026 | $664.08 | $790.61 | $971.40 | -1.64% |
| December 2026 | $667.19 | $796.59 | $983.11 | +0.76% |
Click any year to see its month-by-month MCK forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect MCK to range from $725.17 to $983.11 through 2026. The $756.47 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The MCK price prediction for 2027 points to an average of $858.65 (low $701.46, high $1,100.19) — a potential gain of +14% on today's $756.47. A consolidation phase looks the most probable path here.
In 2028, MCK is projected to trade between $699.76 and $1,146.76, averaging $872.21 — a potential gain of +15% from today's $756.47. That is up +2% on the projected 2027 average. Price action looks broadly range-bound.
McKesson Corporation's 2029 outlook centres on $992.28, within a $784.22 to $1,331.77 range. That is up +14% on the projected 2028 average. That marks a +31% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, MCK could reach as high as $1,497.80, with a base case around $1,096.58 and support toward $855.25 — roughly +45% from $756.47. Momentum favours further upside here.
Expect MCK to range from $944.85 to $1,700.80 through 2031. The $1,226.10 average target implies a +62% move from current prices. That is up +12% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The MCK price prediction for 2032 points to an average of $1,432.36 (low $1,091.58, high $2,014.85) — a potential gain of +89% on today's $756.47. Momentum favours further upside here.
In 2033, MCK is projected to trade between $1,133.63 and $2,141.43, averaging $1,503.09 — a potential gain of +99% from today's $756.47. That is up +5% on the projected 2032 average. Buyers look set to stay in control over this stretch.
McKesson Corporation's 2034 outlook centres on $1,539.01, within a $1,149.36 to $2,218.58 range. That is up +2% on the projected 2033 average. That marks a +103% change versus current levels. Momentum favours further upside here.
By 2035, MCK could reach as high as $2,360.79, with a base case around $1,619.78 and support toward $1,198.40 — roughly +114% from $756.47. Buyers look set to stay in control over this stretch.
Expect MCK to range from $1,749.00 to $3,764.14 through 2040. The $2,465.20 average target implies a +226% move from current prices. That is up +52% on the projected 2035 average. Momentum favours further upside here.
The MCK price prediction for 2050 points to an average of $4,304.01 (low $2,847.67, high $7,042.53) — a potential gain of +469% on today's $756.47. Buyers look set to stay in control over this stretch.
Investing $1,000 in MCK today (≈ 1.321929 MCK) could be worth
$5,689.6
+$4,689.6 (+469%) by 2050 · US Dollar
Based on the average projected MCK price of $4,304.01 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in MCKwould be worth at today's price.
$1,000 invested in MCK on May 27, 2025 (≈ 1.388156 MCK) would be worth
$1,050.1
+$50.1 (+5.0%) today · 1.05× · US Dollar
Based on a MCK entry price of $720.38 vs. today's $756.47.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $754.68 | $1,002.37 | +0.2% |
| 1 month ago | $828.32 | $913.26 | -8.7% |
| 3 months ago | $974.45 | $776.3 | -22.4% |
| 6 months ago | $881.12 | $858.53 | -14.1% |
| 1 year ago | $720.38 | $1,050.1 | +5.0% |
| All time (5.0y) ago | $191.83 | $3,943.44 | +294.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our MCK forecast.
Our base-case forecast reaches $1,500.00 around 2033.
Implied market cap at $1,500.00: $180.31B
The multi-year forecast shows a bullish trajectory with meaningful upside over time. In 2026 the average price is $766.08 with a min of $725.17 and a max of $1,001.47, and the sentiment is NEUTRAL. By 2030, the average rises to $1,133.96 with a max of $1,549.20 and a min of $884.26, delivering an expected ROI of 48% and a bullish outlook.
The forecast continues to rise toward 2040, where the average is $2,599.81 and the max reaches $3,970.11, for an implied ROI of 239.4% and a bullish sentiment. By 2050, the average is $4,584.79 with a max of $7,502.56, representing an ROI of 498.5% and a bullish sentiment. The progression through 2029–2035 remains bullish, with higher upside potential as earnings and fundamentals are implied to improve in the model’s view.
These projections are estimates and not guarantees. They illustrate a path of potential appreciation under certain conditions and should be considered alongside other risk factors and individual investment considerations.
Tap a question to reveal the answer.
Avg price by 2030: $1,133.96; min $884.26; max $1,549.20; ROI 48%; sentiment BULLISH.
The forecast shows a bullish trajectory with average prices rising to $1,133.96 by 2030 and $4,584.79 by 2050, with ROI up to 498.5% by 2050. Near-term sentiment is NEUTRAL, but longer-term outlook is bullish.
Yes. The max forecast by 2040 is $3,970.11, which would exceed $3,000.
Near-term sentiment is NEUTRAL; RSI(14) is 40. The 50-day SMA is $834.14 and the 200-day SMA is $816.49. The 30-day range is $701.55 to $836.54, with support at $725.17 and resistance at $867.34.
Current price is $766.08; market cap is $92.09B.
McKesson Corporation Community Discussion
0Share your McKesson Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.